Additional prognostic impact of the percentage of erythroid cells in the bone marrow of patients with myelodysplastic syndromes.
暂无分享,去创建一个
A. Stamatoullas | J. Bennett | P. Fenaux | P. Valent | W. Sperr | U. Germing | R. Haas | M. Porta | R. Sapena | C. Strupp | M. Rossi | H. Tuechler | A. Guerci | Judith Neukirchen-Strapatsas | M. D. Porta
[1] P. Nguyen,et al. Myelodysplastic syndromes , 2009, Nature Reviews Disease Primers.
[2] P. Ji,et al. Age-related inflammatory bone marrow microenvironment induces ineffective erythropoiesis mimicking del(5q) MDS , 2017, Leukemia.
[3] A nationwide survey of hypoplastic myelodysplastic syndrome (a multicenter retrospective study) , 2017, American journal of hematology.
[4] M. Fontenay,et al. Dyserythropoiesis of myelodysplastic syndromes , 2017, Current opinion in hematology.
[5] S. Méndez-Ferrer,et al. Myeloid malignancies and the microenvironment. , 2017, Blood.
[6] L. Arenillas,et al. Considering Bone Marrow Blasts From Nonerythroid Cellularity Improves the Prognostic Evaluation of Myelodysplastic Syndromes. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] J. Bennett,et al. Dysplastic erythroid precursors in the myelodysplastic syndromes and the acute myeloid leukemias: Is there biologic significance? (How should blasts be counted?). , 2016, Leukemia research.
[8] U. Germing,et al. Cellularity, characteristics of hematopoietic parameters and prognosis in myelodysplastic syndromes , 2015, European journal of haematology.
[9] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[10] U. Germing,et al. Validation and proposals for a refinement of the WHO 2008 classification of myelodysplastic syndromes without excess of blasts. , 2013, Leukemia research.
[11] Luca Malcovati,et al. Revised international prognostic scoring system for myelodysplastic syndromes. , 2012, Blood.
[12] U. Germing,et al. Evaluation of dysplasia through detailed cytomorphology in 3156 patients from the Düsseldorf Registry on myelodysplastic syndromes. , 2012, Leukemia research.
[13] M. Yao,et al. Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies , 2008, Leukemia.
[14] T Hamblin,et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. , 1997, Blood.
[15] G Flandrin,et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. , 1985, Annals of internal medicine.